Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Harry Stylli > Profile

Harry Stylli

Affiliations

  • Chairman & Ceo at Progenity Inc. (PROG), 2021-08-17
  • Director at Molecular Insight Pharmaceuticals Inc. (MIPI), 2010-05-17
  • Officer, Director at Sequenom Inc (SQNM), 2009-03-16
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
PROG $3.27 152,905 $499,999.35 14,616,874 2020-12-02 Filing
PROG $8.94 10,000 $89,400.00 14,463,969 2020-08-19 Filing
PROG $15.00 33,333 $499,995.00 1,038,635 2020-06-19 Filing
SQNM $13.44 900 $12,096.00 142,511 2009-03-13 Filing
SQNM $13.43 300 $4,029.00 141,611 2009-03-13 Filing